Clinical Trials on T Cell Immunodeficiency Primary
Total 7612 results
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedExtranodal NK-T-Cell Lymphoma, Nasal TypeChina
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Novartis PharmaceuticalsTerminatedCutaneous T-Cell LymphomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
University of California, San FranciscoWashington University School of Medicine; Eisai Inc.TerminatedPeripheral T-Cell LymphomaUnited States
-
OctapharmaCompletedPrimary ImmunodeficiencyUnited Kingdom, Australia, Germany, Italy
-
Instituto de Investigación Biomédica de SalamancaCarlos III Health InstituteRecruitingCutaneous T-Cell LymphomaSpain
-
University of MiamiRecruitingAdult T-cell Leukemia-Lymphoma | ATLLUnited States
-
Rong TaoCompletedSocial Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL PatientsExtranodal NK-T-Cell Lymphoma, Nasal TypeChina
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; 307 Hospital of PLA; Qilu Hospital of Shandong... and other collaboratorsUnknownExtranodal Natural Killer/T-Cell Lymphoma, Nasal TypeChina
-
Nanjing NingQi Medicine Science and Technology...Jiangsu Cancer Institute & HospitalUnknownPeripheral T-cell LymphomasChina
-
Mingzhi ZhangShanxi Province Cancer Hospital; Wuhan University; Qingdao University; Wuhan Union... and other collaboratorsUnknownNasal and Nasal-type NK/T-cell LymphomaChina
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingRelapsed or Refractory Peripheral T-cell Lymphoma (PTCL)China
-
Chinese PLA General HospitalRecruitingAdvanced Lymphoma | Newly Diagnosed | nk/T-cell LymphomaChina
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...RecruitingNon-Hodgkin's Lymphoma (NHL) | Peripheral T Cell Lymphoma (PTCL)China
-
Kyowa Kirin, Inc.CompletedAdult T-cell Leukemia-LymphomaUnited States, United Kingdom, Belgium, France, Brazil, Peru
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedExtranodal NK-T-Cell Lymphoma, Nasal TypeChina
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompleted
-
Mingzhi ZhangShanxi Province Cancer Hospital; Wuhan University; Qingdao University; Wuhan Union... and other collaboratorsUnknownNasal and Nasal-type NK/T-cell LymphomaChina
-
Ontario Clinical Oncology Group (OCOG)Sunnybrook Health Sciences Centre; Genzyme, a Sanofi CompanyCompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas (ACCAPELA)Peripheral T-cell LymphomasCanada
-
SoligenixCompletedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States
-
Moleculin Biotech, Inc.CompletedCutaneous T-Cell Lymphoma/Mycosis FungoidesPoland
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Belgium
-
Millennium Pharmaceuticals, Inc.CompletedMantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | Burkitt's Lymphoma | T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma | Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell ComponentUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Cutaneous T-cell Non-Hodgkin LymphomaUnited States
-
Ellen Kim, MDSoligenixRecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
University of PittsburghCompletedSezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
University of Alabama at BirminghamSeagen Inc.; Kyowa Kirin, Inc.RecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
Eisai Inc.Dr. Reddy's Laboratory; Citius PharmaceuticalsCompletedPersistent or Recurrent Cutaneous T-Cell LymphomaUnited States, Australia, Puerto Rico
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First Affiliated Hospital of Zhengzhou UniversityUnknownAcute Lymphocytic Leukemia | T-lymphoblastic Lymphoma | NK/T Cell LymphomaChina
-
Washington University School of MedicineMerck Sharp & Dohme LLCWithdrawnHuman T-cell Leukemia Virus Type 1 Infection
-
Stanford UniversityTerminatedCutaneous T-cell Lymphoma | Cutaneous LymphomaUnited States
-
Rennes University HospitalCompletedHypertriglyceridemia | Cutaneous T Cell LymphomaFrance
-
Beijing Boren HospitalNanjing Legend Biotech Co.TerminatedT-cell Leukemia | T Cell LymphomaChina
-
Fundamenta Therapeutics, Ltd.The First Affiliated Hospital of University of Science and Technology of...RecruitingT-Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin Lymphoma | T-cell Acute Lymphoblastic LymphomaChina
-
Portola PharmaceuticalsWithdrawnAITL | Peripheral T-Cell Lymphoma (PTCL NOS) | Nodal Lymphomas of T Follicular Helper (TFH) | Follicular T-cell Lymphoma (FTCL) | ALCL | HSTCL | EATL I,II | MEITL, EATL Type II | Nasal Lymphoma
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin LymphomaUnited States
-
University of Rome Tor VergataUniversity Of Perugia; University of L'AquilaCompletedBladder Cancer TNM Staging Primary Tumor (T) Ta | Bladder Cancer TNM Staging Primary Tumor (T) T1 | Bladder Cancer Transitional Cell GradeItaly
-
Seagen Inc.TerminatedHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
Keimyung University Dongsan Medical CenterOtsuka Pharmaceutical Co., Ltd.RecruitingLymphoma, Extranodal NK-T-Cell | T-cell Non-Hodgkin LymphomaKorea, Republic of
-
Huiqiang HuangSun Yat-sen UniversityRecruitingExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
TakedaCompletedPeripheral T Cell Lymphoma | Pediatric Hodgkin LymphomaJapan
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingNon Hodgkin Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Peking Union Medical College HospitalPeking University First Hospital; Chinese PLA General Hospital; Peking University... and other collaboratorsRecruitingT Cell Non-Hodgkin's LymphomaChina
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada